Target intelligence / Profile preview

Reactive oxygen species, toxic carbonyls, free radicals, and redox-active metals (ROS/RCS)

Target
ROS/RCS
Molecular classification
Reactive species, Metal ions, Small molecules
01

Overview

Reactive oxygen species (ROS), toxic reactive carbonyl species (RCS), free radicals, and redox-active metals represent a heterogeneous group of highly reactive chemical entities that mediate oxidative and carbonyl stress within biological systems [PMID: 28249116]. ROS and free radicals, such as superoxide and hydroxyl radicals, are natural byproducts of mitochondrial metabolism and immune response but can cause extensive damage to DNA, proteins, and lipids when produced in excess [PMID: 22229205]. Toxic carbonyls, often derived from lipid peroxidation or sugar oxidation, further exacerbate cellular damage by forming stable adducts with macromolecules, a process linked to aging and chronic diseases like diabetes [PMID: 24563248]. Redox-active metals like iron and copper catalyze the formation of the highly destructive hydroxyl radical via the Fenton and Haber-Weiss reactions [PMID: 11115402]. Pharmacological intervention typically involves the use of scavengers, antioxidants, or chelating agents to neutralize these species or prevent their formation [PMID: 30509180]. While these entities are critical drivers of pathology in neurodegeneration, cardiovascular disease, and cancer, they also play essential roles in physiological cell signaling, making systemic inhibition a significant therapeutic challenge [PMID: 25236452].

Other names
Pro-oxidantsReactive oxygen and nitrogen species (RONS)Oxidative stress mediatorsReactive carbonyl species (RCS)Reactive species
02

Mechanism of action

Neutralization of reactive species through electron donation (scavenging), enzymatic degradation, or sequestration of catalytic metal ions (chelation) [PMID: 30509180].

03

Biological functions

Redox signalingOxidative stress responseCellular homeostasisApoptosis inductionInnate immune response
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerDiabetes mellitusInflammationAging
05

Safety considerations

Interference with essential physiological redox signalingPotential for pro-oxidant activity at high concentrationsLack of tissue specificityAntioxidant paradox (clinical trial failures despite mechanistic rationale)
06

Interacting drugs

Edaravone

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsF2-isoprostanesGlutathione (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive oxygen species, toxic carbonyls, free radicals, and redox-active metals (ROS/RCS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species, toxic carbonyls, free radicals, and redox-active metals (ROS/RCS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call